Inspection findings FDA conducted an inspection of Zoll's Chelmsford, Massachusetts facility from February 27, 2025 through April 15, 2025, determining that the company manufactures X Series/Advanced automated external defibrillators (AEDs) (Class 3), Zoll MRI Compatible 731 Ventilators (Class 2), OneStep electrodes (Class 3), and Accuvent Sensors (Class 3)
M.BakH.YimS
A "hard" denial based on a plan exclusion means your plan literally does not cover the category of medication
In one study of retatrutide, the newest type of triple agonist weight-loss drug, studies found that people lose an average of 30% of their body weight over 80 weeks
A further dimension emerged in May 2026, when the ATTAIN-MAINTAIN trial, published in Nature Medicine , found that patients who switched to orforglipron after achieving substantial weight loss on injectable GLP-1s maintained approximately 7580% of that weight reduction
Results of others indicated that down-regulation of Mecp2 for 5 days decreased neuronal dendritic complexity [378]
